ARTA
AMRX icon

A.R.T. Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

A.R.T. Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-104,515
Closed -$504K – 93
2019
Q4 		$504K Sell
104,515
-62,320
-37% -$217K 0.02% 853
2019
Q3 		$484K Buy
166,835
+124,700
+296% +$435K 0.02% 876
2019
Q2 		$302K Sell
42,135
-23,000
-35% -$235K 0.02% 953
2019
Q1 		$923K Buy
65,135
+45,400
+230% +$600K 0.06% 515
2018
Q4 		$267K Sell
19,735
-33,400
-63% -$602K 0.02% 970
2018
Q3 		$1.18M Buy
53,135
+15,600
+42% +$328K 0.05% 503
2018
Q2 		$615K Buy
+37,535
New +$659K 0.03% 840

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return